
COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

Pharmafocus December edition is available to read online now!

It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …

Friday again, and we bring you the most read articles on our site this week – one of which was …

This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …

As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life …

The Spring 2017 edition of Pharmafile, our bi-annual market intelligence report for the life sciences industry, is available to read …